Translate
Glenmark Pharmaceuticals Limited
About
Glenmark Pharmaceuticals Limited (NSE:GLENMARK) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 9 2026
Press Release Apr 09 2026
Apr 1 2026
Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S., Significantly Expanding Its Innovative Portfolio
Mar 21 2026
Press Release Mar 21 2026
Mar 19 2026
Press Release Mar 19 2026
Mar 16 2026
Press Release Mar 16 2026
Financials
Revenue
₹165.1 B
Market Cap
₹588.31 B
P/E Ratio
55.35
EPS
37.65